Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-06-23 | New | $5,500,000 | $5,500,000 | Equity Only | 06b | SEC link |
| 2024-09-23 | New | $3,207,000 | $3,207,000 | Equity Only | 06b | SEC link |
| 2021-06-29 | New | $12,477,342 | Unknown | Equity Only | SEC link | |
| 2021-02-12 | New | $14,003,334 | $14,003,334 | Equity Only | 06b | SEC link |
| 2013-09-05 | New | $11,533,375 | $11,533,375 | Equity Only | 06 | SEC link |
| 2013-03-13 | New | $9,073,300 | $9,073,300 | Equity Only | 06 | SEC link |
| Name | Role |
|---|---|
| John Abeles | Director |
| Daniel Alkon | Director, Executive |
| Ralph Bean | Director |
| Bruce T. Bernstein | Director |
| James New | Director, Executive |
| George Perry | Director |
| Eric Rubenstein | Director |
| Jonathan L. Schechter | Director |
| Joshua Silverman | Director, Executive |
| William Singer | Director |
| Alan J. Tuchman | Director, Executive |
| Robert Weinstein | Executive |